KM Research Hub

LITERATURE

原始候选快照

v3 复核前的候选池,完整保留,仅供查看,不会自动重新处理。 共 7004 篇。

导出 CSV
论文标识日期入排置信度入排依据KM 状态
Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma: An Exploratory Analysis of AGO-OVAR11/ICON-7.Lab InvestPMID 38154497无 PMCID2024-Apr0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial.Lancet Respir MedPMID 38184008无 PMCID2024-Apr0.98未发现恶性肿瘤人群证据。待处理
Safety Analyses of the Phase 3 VISION Trial of [177Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer.Eur UrolPMID 38185538PMC118597172024-Apr0.96主要研究目的为安全性/毒性或卫生经济学,未见合格 time-to-event 疗效终点。待处理
The antioxidant and anti-inflammatory activities of avasopasem manganese in age-associated, cisplatin-induced renal injury.Redox BiolPMID 38215546PMC108211642024-Apr0.98未发现恶性肿瘤人群证据。待处理
Anaesthetic efficacy and postinduction hypotension with remimazolam compared with propofol: a multicentre randomised controlled trial.AnaesthesiaPMID 38221513无 PMCID2024-Apr0.98未发现恶性肿瘤人群证据。待处理
Prusogliptin (DBPR108) monotherapy in treatment-naïve patients with type 2 diabetes: A randomized, double-blind, active and placebo-controlled, phase 3 study.Diabetes Obes MetabPMID 38221859无 PMCID2024-Apr0.98未发现恶性肿瘤人群证据。待处理
A phase 3 randomized study to evaluate safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in healthy Japanese infants.Int J Infect DisPMID 38242195无 PMCID2024-Apr0.98未发现恶性肿瘤人群证据。待处理
The efficacy and safety of fexuprazan in treating erosive esophagitis: a phase III, randomized, double-blind, multicenter study.J Gastroenterol HepatolPMID 38251791无 PMCID2024-Apr0.98未发现恶性肿瘤人群证据。待处理
Reply of the Authors: Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.Fertil SterilPMID 38266801无 PMCID2024-Apr0.99记录类型属于综述、Meta 分析、社论、评论、病例或指南。待处理
Moderate hypofractionated radiotherapy for prostate cancer: 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial.Radiother OncolPMID 38278333无 PMCID2024-Apr0.80The record describes a randomized phase 3 trial for prostate cancer (oncology, human), but it reports only toxicity outcomes (acute and late gastrointestinal and urinary toxicity) as primary and secondary endpoints. It does not report survival, progression, recurrence, death, hazard, or other time-to-event efficacy outcomes required for inclusion in this Kaplan-Meier digitization cohort.待处理
Vutrisiran: a new drug in the treatment landscape of hereditary transthyretin amyloid polyneuropathy.Expert Opin Drug DiscovPMID 38281068无 PMCID2024-Apr0.98未发现恶性肿瘤人群证据。待处理
Efficacy and Safety of Ponesimod Compared with Teriflunomide in Female Patients with Relapsing Multiple Sclerosis: Findings from the Pivotal OPTIMUM Study.J Womens Health (Larchmt)PMID 38301149无 PMCID2024-Apr0.98未发现恶性肿瘤人群证据。待处理
A phase 3, randomized, placebo-controlled, trial to evaluate the efficacy and safety of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related posttraumatic stress disorder.Psychiatry ResPMID 38350291无 PMCID2024-Apr0.98未发现恶性肿瘤人群证据。待处理
Safety and efficacy of atogepant for the preventive treatment of episodic migraine in adults for whom conventional oral preventive treatments have failed (ELEVATE): a randomised, placebo-controlled, phase 3b trial.Lancet NeurolPMID 38364831无 PMCID2024-Apr0.98未发现恶性肿瘤人群证据。待处理
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study.Lancet Gastroenterol HepatolPMID 38364832无 PMCID2024-Apr0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Effective growth hormone replacement with once-weekly somapacitan in Japanese children with growth hormone deficiency: Results from REAL4, a phase 3 clinical trial.Clin Endocrinol (Oxf)PMID 38368603无 PMCID2024-Apr0.98未发现恶性肿瘤人群证据。待处理
Prognostic and predictive value of non-steroidal anti-inflammatory drugs in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma.Eur J CancerPMID 38402687无 PMCID2024-Apr0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
A Randomized, Phase 3, Double-Blind, Crossover Comparison of Multilayer, Extended-Release Methylphenidate (PRC-063), and Lisdexamfetamine in the Driving Performance of Young Adults With ADHD.J Atten DisordPMID 38404033PMC109811712024-Apr0.98未发现恶性肿瘤人群证据。待处理
Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR-Preserved analysis.Eur J Heart FailPMID 38439585无 PMCID2024-Apr0.98未发现恶性肿瘤人群证据。待处理
Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer.Gynecol OncolPMID 38490057无 PMCID2024-Apr0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.Lancet NeurolPMID 38508835无 PMCID2024-Apr0.98未发现恶性肿瘤人群证据。待处理
High-Dose Quadrivalent Influenza Vaccine for Prevention of Cardiovascular and Respiratory Hospitalizations in Older Adults.Influenza Other Respir VirusesPMID 38569647PMC109906792024-Apr0.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus: A 24-week, randomized, double-blind, active-controlled, phase 3 trial.J DiabetesPMID 38584148PMC109994972024-Apr0.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of tocilizumab in Japanese patients with systemic sclerosis and associated interstitial lung disease: A subgroup analysis of a global, randomised, controlled Phase 3 trial.Mod RheumatolPMID 37436828无 PMCID2024-Mar-280.98未发现恶性肿瘤人群证据。待处理
Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study.RMD OpenPMID 38531621PMC109668002024-Mar-260.98未发现恶性肿瘤人群证据。待处理
Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial.J Immunother CancerPMID 38531663PMC109668122024-Mar-260.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Long-term treatment with lasmiditan in patients with migraine: post hoc analysis of treatment patterns and outcomes from the open-label extension of the CENTURION randomized trial.J Headache PainPMID 38528476PMC109645392024-Mar-250.98未发现恶性肿瘤人群证据。待处理
Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial.LancetPMID 38402887PMC109858392024-Mar-230.98未发现恶性肿瘤人群证据。待处理
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial.LancetPMID 38461841无 PMCID2024-Mar-230.98未发现恶性肿瘤人群证据。待处理
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.LancetPMID 38461843无 PMCID2024-Mar-230.98未发现恶性肿瘤人群证据。待处理
Ribociclib plus Endocrine Therapy in Early Breast Cancer.N Engl J MedPMID 38507751无 PMCID2024-Mar-210.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir.Clin Infect DisPMID 38036487PMC109543272024-Mar-200.98未发现恶性肿瘤人群证据。待处理
Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study.J Clin OncolPMID 38232341无 PMCID2024-Mar-201.00命中用户提供的消化道肿瘤阳性参考集。待处理
Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials.BMJ OpenPMID 38508632PMC109529372024-Mar-190.98未发现恶性肿瘤人群证据。待处理
Impact of Interfractional Bladder and Trigone Displacement and Deformation on Radiation Exposure and Subsequent Acute Genitourinary Toxicity: A Post Hoc Analysis of Patients Treated with Magnetic Resonance Imaging-Guided Prostate Stereotactic Body Radiation Therapy in a Phase 3 Randomized Trial.Int J Radiat Oncol Biol PhysPMID 37871887无 PMCID2024-Mar-150.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Physician- and Patient-Reported Outcomes of the MC1635 Phase 3 Trial of Ultrahypofractionated Versus Moderately Hypofractionated Adjuvant Radiation Therapy After Breast-Conserving Surgery.Int J Radiat Oncol Biol PhysPMID 37914139无 PMCID2024-Mar-150.95The study is a randomized Phase III oncology trial but does not meet the inclusion criteria because the intervention is radiation therapy (non-drug) and the primary endpoints are toxicity and cosmesis, not a time-to-event efficacy endpoint (OS, PFS, DFS, EFS, RFS, TTP) or a Kaplan-Meier/HR analysis.待处理
Dasiglucagon for the Treatment of Congenital Hyperinsulinism: A Randomized Phase 3 Trial in Infants and Children.J Clin Endocrinol MetabPMID 37930757PMC109402632024-Mar-150.98未发现恶性肿瘤人群证据。待处理
Genetic and T2 biomarkers linked to the efficacy of HDM sublingual immunotherapy in asthma.ThoraxPMID 38160049无 PMCID2024-Mar-150.98未发现恶性肿瘤人群证据。待处理
Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia.Parasit VectorsPMID 38491528PMC109438942024-Mar-150.98未发现恶性肿瘤人群证据。待处理
High Risk of New HPV Infection Acquisition Among Unvaccinated Young Men.J Infect DisPMID 38012959PMC109381972024-Mar-140.98未发现恶性肿瘤人群证据。待处理
RSV Prefusion F Protein-Based Maternal Vaccine - Preterm Birth and Other Outcomes.N Engl J MedPMID 38477988无 PMCID2024-Mar-140.98未发现恶性肿瘤人群证据。待处理
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial.J Immunother CancerPMID 38485189PMC109411962024-Mar-130.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3: The Phase 2 TOPAZ Study.NeurologyPMID 38330285PMC110677002024-Mar-120.98未发现恶性肿瘤人群证据。待处理
Neoadjuvant-adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial.Nat CommunPMID 38461323PMC109250212024-Mar-090.96主要研究目的为安全性/毒性或卫生经济学,未见合格 time-to-event 疗效终点。待处理
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma.Cancer Res CommunPMID 38363156PMC109192072024-Mar-070.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Safety and immunogenicity of the NVX-CoV2373 vaccine as a booster in adults previously vaccinated with the BBIBP-CorV vaccine.VaccinePMID 38365482无 PMCID2024-Mar-070.98未发现恶性肿瘤人群证据。待处理
Effect of Clot Burden Score on Safety and Efficacy of Intravenous Alteplase Prior to Mechanical Thrombectomy in Acute Ischemic Stroke: A Subgroup Analysis of a Randomized Phase 3 Trial.AJNR Am J NeuroradiolPMID 38388688PMC112861112024-Mar-070.98未发现恶性肿瘤人群证据。待处理
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.N Engl J MedPMID 38393328无 PMCID2024-Mar-070.98未发现恶性肿瘤人群证据。待处理
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.N Engl J MedPMID 38446675无 PMCID2024-Mar-070.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Early Enzymatic Burn Debridement: Results of the DETECT Multicenter Randomized Controlled Trial.J Burn Care ResPMID 37715999无 PMCID2024-Mar-040.98未发现恶性肿瘤人群证据。待处理